Balance Sheet Components (Tables)

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consists of the following (in thousands):

	As of December 31,
	2025		2024
Accounts receivable and other receivables	$	2,177	$	2,171
Prepaid clinical research & development costs	7,280		6,473
Prepaid manufacturing and other research & development costs	10,249		16,196
Other prepaid assets and other current assets	13,073		7,265
Total prepaid expenses and other current assets	$	32,779	$	32,105

Schedule of Property and Equipment, Net

Property and equipment, net consists of the following (in thousands):

	As of December 31,
	2025		2024
Leasehold improvements	$	47,755	$	46,905
Laboratory equipment	45,797		40,554
Manufacturing equipment	17,493		15,998
Computer equipment and purchased software	2,203		1,841
Furniture and fixtures	2,049		1,980
Total property and equipment	115,297		107,278
Less: accumulated depreciation	(62,895)		(52,042)
Total property and equipment, net	$	52,402	$	55,236

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consists of the following (in thousands):

	As of December 31,
	2025		2024
Accrued compensation	$	32,179	$	24,728
Accrued clinical and other research & development costs	19,458		22,822
Accrued manufacturing costs	5,336		12,779
Operating lease liability, current	9,463		8,308
Finance lease liability, current	83		3,726
Deferred research and development funding liability, current	21,101		14,129
Other accrued costs and current liabilities	7,401		4,579
Total accrued expenses and other current liabilities	$	95,021	$	91,071